ADHD Medication: Benefits, Risks, & Common Questions
ADHD
Medication:
Benefits, Risks,
& Common Questions
An honest, evidence-based guide for parents navigating one of the most common — and most misunderstood — decisions in child psychiatry.
When a child is diagnosed with ADHD, one of the first questions parents ask me is: "Do they really need medication?" It's the right question to ask. And it deserves a real answer — not a dismissal, not a rushed prescription, and not the kind of fear-based refusal that leaves a child struggling unnecessarily for years. Let's talk about what the evidence actually says.
As a child and adolescent psychiatrist, I have this conversation with families regularly. The decision to start, adjust, or decline ADHD medication is deeply personal — and it should be made with accurate information, clinical guidance, and your values as a family front and center. This post is designed to give you that foundation.
What ADHD Actually Is — and Why It Matters for Medication
ADHD is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that are inconsistent with developmental level and interfere meaningfully with functioning. It is not a behavior problem. It is not the result of bad parenting. It is not caused by too much screen time or sugar.
Brain imaging research consistently shows that children with ADHD have differences in the development and activity of the prefrontal cortex — the region responsible for attention, planning, impulse control, and working memory. These differences are associated with dysregulation of dopamine and norepinephrine, the neurotransmitters that ADHD medications are specifically designed to support.
Understanding this matters for the medication conversation because it reframes the question. We are not sedating a wild child. We are supporting a brain that is neurologically undersupplied with the chemicals it needs to regulate attention and behavior.
Types of ADHD Medication: What's Actually Out There
There are three main categories of ADHD medication. Understanding the differences helps parents have more informed conversations with their prescribing clinician.
Stimulants
The most studied and most effective class of ADHD medication. They work by increasing dopamine and norepinephrine availability in the brain. Divided into two families: methylphenidate-based and amphetamine-based. Available in short-acting and long-acting formulations.
Examples: Adderall, Vyvanse, Ritalin, Concerta, FocalinAtomoxetine
A selective norepinephrine reuptake inhibitor (SNRI) that builds effect gradually over 4–8 weeks. Preferred when stimulants are ineffective, poorly tolerated, or when co-occurring anxiety is present. Not a controlled substance — an advantage for some families.
Brand name: StratteraGuanfacine & Clonidine
Used as standalone treatments or in combination with stimulants. Particularly effective for hyperactivity, impulsivity, emotional dysregulation, and sleep difficulties associated with ADHD. Often used in younger children or those with tic disorders.
Brand names: Intuniv, KapvayBenefits & Risks: The Honest Picture
Parents deserve a balanced, evidence-based accounting of both what medication can do and what its limitations and risks are. Here is that picture, as clearly as I can give it.
- Significant reduction in core ADHD symptoms in 70–80% of children
- Improved academic performance, task completion, and classroom behavior
- Better working memory and sustained attention
- Reduction in accidental injuries — ADHD is a risk factor for accidents
- Improved peer relationships and social functioning
- Reduced risk of substance use disorders in adolescence — contrary to popular belief, treated ADHD lowers this risk
- Decreased risk of academic failure and school dropout
- Improved self-esteem when functioning improves meaningfully
- Appetite suppression — often most significant at midday; typically managed with timing adjustments
- Sleep difficulties — particularly with afternoon doses; addressed with timing or formulation changes
- Mild increase in heart rate and blood pressure — requires monitoring; rarely clinically significant in healthy children
- Headaches or stomachaches — often transient, occurring in the first 1–2 weeks
- Emotional blunting or "zombie" feeling — a signal to adjust dose or try a different medication
- Rebound irritability as medication wears off — managed with dose timing or extended-release formulations
- Potential for mild growth deceleration with long-term use — monitored routinely
Medication does not change who your child is. When the dose is right, parents consistently tell me: "I feel like I finally got my kid back." The goal is never compliance. It's access — to learning, to friendships, to the full life they deserve.
— Dr. Farrah Laviolette, MD, Cranbrook Psychiatric GroupMyths vs. Evidence: What Parents Most Often Get Wrong
- "ADHD medication will turn my child into a zombie." A flat, robotic affect is a sign of too high a dose — not an inevitable side effect. It should prompt a dose adjustment, not medication abandonment.
- "Stimulants are addictive." When used as prescribed, stimulant medications are not addictive in children with ADHD. Research consistently shows that treated ADHD actually reduces — not increases — future substance use risk.
- "My child will need medication forever." Some children eventually no longer meet criteria for ADHD or find their symptoms manageable without medication as their brain matures. Treatment is reassessed regularly.
- "Medication is a shortcut — they should just try harder." Asking a child with ADHD to simply try harder without support is like asking a child with poor vision to try harder to read the board. The problem is neurological, not motivational.
- "Behavioral therapy should always come first." For school-age children with moderate-to-severe ADHD, evidence supports medication as a highly effective first-line intervention — often combined with therapy for the best outcomes.
- "The dose that works now will always work." Children grow. Weight, brain development, and life demands all change. Medication management is an ongoing clinical process, not a one-time decision.
Questions Parents Ask Me Most
At what age can a child start ADHD medication?
The FDA approves stimulant medications for children as young as age 6 for most formulations. For children aged 4–5, the American Academy of Pediatrics recommends behavioral therapy as the primary first-line treatment, with medication considered if symptoms are severe or therapy is insufficient. There is no single right age — it depends on the severity of symptoms, the impact on functioning, and the family's goals and values.
How do we know if the medication is working?
We look for meaningful, observable improvement in the areas where ADHD was causing the most impairment — typically attention, task completion, impulse control, and academic or social functioning. I use standardized rating scales (like the Vanderbilt or Conners) completed by parents and teachers before and after medication starts. If we don't see improvement, or if side effects are significant, we adjust. Finding the right medication and dose is a process — it often takes a few trials to optimize.
Should my child take medication on weekends and school breaks?
This is a clinical and family decision, not a universal rule. Some children benefit from consistent daily dosing — ADHD affects functioning at home and in social settings, not just at school. Others do well taking breaks on weekends to support appetite and growth. Some families take "medication holidays" during summer to reassess need. I discuss this individually with each family based on the child's profile and goals.
What if we try medication and decide it's not right for our family?
Stimulant medication is not a long-term commitment you can't reverse. If you try it and decide the side effects outweigh the benefits, or if it simply doesn't feel right, you stop. There are no significant withdrawal effects with stimulants. Non-stimulants like Strattera require a taper, but the decision to stop is always yours. A trial of medication — managed carefully — carries far less long-term risk than years of unmanaged ADHD.
Does medication replace therapy and other supports?
No — and I want to be clear about this. Medication addresses the neurological substrate of ADHD. It does not teach organizational skills, social skills, or emotional regulation strategies. The best outcomes are consistently associated with combined treatment: medication to support brain function, and behavioral or cognitive therapy, parent training, and school accommodations to build skills and structure. Medication opens the door. Everything else helps your child walk through it.
What should I tell my child about their medication?
Be honest, age-appropriate, and framing matters enormously. Avoid framing medication as something for "bad behavior." Instead: "Your brain works differently in a way that makes it harder to focus. This medicine helps your brain do what you want it to do — it's like glasses for your attention." Involving your child in the conversation supports their sense of agency and reduces stigma. Older children and adolescents especially need to understand and agree with the plan for it to succeed.
What Good Medication Management Looks Like
Starting ADHD medication is not a hand-off. It is the beginning of an ongoing clinical relationship. Here is what you should expect from any responsible prescribing clinician:
- A comprehensive diagnostic evaluation before any prescription is written — not just a 15-minute appointment
- Baseline measurements of height, weight, heart rate, and blood pressure — and regular monitoring thereafter
- Standardized rating scales completed by parents and teachers before and after medication starts
- Clear communication about what to expect in the first 1–2 weeks, and when to call
- Follow-up within 2–4 weeks of starting or adjusting any medication
- Regular reassessment of whether medication is still needed, appropriate, and at the right dose
- Conversations — not assumptions — about your family's goals, values, and concerns at every visit
- A prescription written at a first appointment without a thorough evaluation
- No follow-up scheduled after starting a new medication
- Dismissal of your concerns about side effects without a plan to address them
- No communication with your child's school or therapist as part of the treatment plan
- A dose that hasn't been reassessed in over a year despite your child growing significantly
- Being told medication is the only treatment your child needs
You Know Your Child. We Know the Evidence. Together We Make the Right Call.
There is no single right answer to whether your child should take ADHD medication. What I can tell you is this: the decision should be made with complete information, without shame, and in partnership with a clinician who takes both the science and your family's values seriously.
Untreated ADHD carries its own very real risks — academic failure, social difficulty, low self-esteem, higher rates of anxiety and depression, and increased accident risk. These costs are often invisible because they accrue slowly, in the background of a child's daily life. The question is never "medication versus no medication." The question is always: what does this child need to thrive?
This post is for educational purposes and does not constitute individualized clinical advice. ADHD treatment decisions should always be made in collaboration with a qualified child psychiatrist or developmental pediatrician who knows your child.
At Cranbrook Psychiatric Group, Dr. Farrah Laviolette, MD provides comprehensive ADHD evaluations and ongoing medication management for children and adolescents in Troy, Michigan. We welcome families who have questions, concerns about a current prescription, or who are seeking a second opinion. You are always welcome to reach out.
- Centers for Disease Control and Prevention. (2022). Data and Statistics on ADHD. CDC.gov.
- Cortese, S. et al. (2018). Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry, 5(9), 727–738.
- MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for ADHD. Archives of General Psychiatry, 56(12), 1073–1086.
- Brown, R.T. et al. (2001). Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics, 107(3), e43.
- American Academy of Pediatrics. (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of ADHD in children and adolescents. Pediatrics, 144(4).
- Wilens, T.E. et al. (2003). Does stimulant therapy of ADHD beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111(1), 179–185.
- Swanson, J.M. et al. (2017). Young adult outcomes in the follow-up of the Multimodal Treatment Study of ADHD. Journal of Child Psychology and Psychiatry, 58(6), 663–678.
